In 2024, GLP-1 agonists (Ozempic, Wegovy, Zepbound) seemed to officially take over the U.S. health care system. Consider some of the rapid changes we’ve witnessed this year. The British Medical Journal (BMJ)... Read more »
Addicts in recovery will eventually feel the pain of loss. The drug of choice is no longer a healthy option for coping and a new one must emerge. In addition, all the... Read more »